302 related articles for article (PubMed ID: 27285585)
1. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
[TBL] [Abstract][Full Text] [Related]
2. Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan.
Nath K; Nelson DS; Heitjan DF; Zhou R; Leeper DB; Glickson JD
NMR Biomed; 2015 Mar; 28(3):395-403. PubMed ID: 25702942
[TBL] [Abstract][Full Text] [Related]
3. Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin.
Nath K; Nelson DS; Heitjan DF; Leeper DB; Zhou R; Glickson JD
NMR Biomed; 2015 Mar; 28(3):281-90. PubMed ID: 25504852
[TBL] [Abstract][Full Text] [Related]
4. Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin.
Nath K; Roman J; Nelson DS; Guo L; Lee SC; Orlovskiy S; Muriuki K; Heitjan DF; Pickup S; Leeper DB; Blair IA; Putt ME; Glickson JD
Sci Rep; 2018 Oct; 8(1):14654. PubMed ID: 30279592
[TBL] [Abstract][Full Text] [Related]
5. (31) P and (1) H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan.
Nath K; Nelson DS; Ho AM; Lee SC; Darpolor MM; Pickup S; Zhou R; Heitjan DF; Leeper DB; Glickson JD
NMR Biomed; 2013 Jan; 26(1):98-105. PubMed ID: 22745015
[TBL] [Abstract][Full Text] [Related]
6. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
7. Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard.
van Putten LM; Lelieveld P
Eur J Cancer (1965); 1971 Feb; 7(1):11-6. PubMed ID: 5576726
[No Abstract] [Full Text] [Related]
8. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
Valeriote FA; Tolen SJ
Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955
[No Abstract] [Full Text] [Related]
9. Thermolabile adenine adducts and A.T base pair substitutions induced by nitrogen mustard analogues in an SV40-based shuttle plasmid.
Wang P; Bauer GB; Bennett RA; Povirk LF
Biochemistry; 1991 Dec; 30(49):11515-21. PubMed ID: 1660721
[TBL] [Abstract][Full Text] [Related]
10. Effects of alkylating agents on the DNA replication of cultured Yoshida sarcoma cells.
van der Steen J; van Wichen BH; Benckhuysen C
Chem Biol Interact; 1982 Mar; 39(2):191-204. PubMed ID: 7060227
[TBL] [Abstract][Full Text] [Related]
11. Effect of Lonidamine on Systemic Therapy of DB-1 Human Melanoma Xenografts with Temozolomide.
Nath K; Nelson DS; Roman J; Putt ME; Lee SC; Leeper DB; Glickson JD
Anticancer Res; 2017 Jul; 37(7):3413-3421. PubMed ID: 28668829
[TBL] [Abstract][Full Text] [Related]
12. Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.
Schwartz GN; Teicher BA; Eder JP; Korbut T; Holden SA; Ara G; Herman TS
Cancer Chemother Pharmacol; 1993; 32(6):455-62. PubMed ID: 8258194
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft.
Lilley ER; Rosenberg MC; Elion GB; Colvin OM; Bigner DD; Friedman HS
Cancer Res; 1990 Jan; 50(2):284-7. PubMed ID: 2295068
[TBL] [Abstract][Full Text] [Related]
14. Transcription-terminating lesions induced by bifunctional alkylating agents in vitro.
Pieper RO; Futscher BW; Erickson LC
Carcinogenesis; 1989 Jul; 10(7):1307-14. PubMed ID: 2736721
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
Singh RK; Kumar S; Prasad DN; Bhardwaj TR
Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739
[TBL] [Abstract][Full Text] [Related]
16. Thermal sensitisation by lonidamine of human melanoma cells grown at low extracellular pH.
Coss RA; Storck CW; Wells TC; Kulp KA; Wahl M; Leeper DB
Int J Hyperthermia; 2014 Feb; 30(1):75-8. PubMed ID: 24295212
[TBL] [Abstract][Full Text] [Related]
17. Modulation of alkylating agents by lonidamine in vivo.
Teicher BA; Holden SA; Herman TS; Frei E
Semin Oncol; 1991 Apr; 18(2 Suppl 4):7-10. PubMed ID: 1903216
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
Létourneau S; Palerme JS; Delisle JS; Beauséjour CM; Momparler RL; Cournoyer D
Cancer Gene Ther; 2000 May; 7(5):757-65. PubMed ID: 10830723
[TBL] [Abstract][Full Text] [Related]
19. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
20. Excision of DNA adducts of nitrogen mustards by bacterial and mammalian 3-methyladenine-DNA glycosylases.
Mattes WB; Lee CS; Laval J; O'Connor TR
Carcinogenesis; 1996 Apr; 17(4):643-8. PubMed ID: 8625472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
